ad image

Hepatitis

1 / 1
Novo Nordisk
Commercial Agreement

Dicerna™ Enters Agreement with Roche to Develop and Commercialize DCR-HBVS for the Treatment of Chronic Hepatitis B Virus (HBV) Infection

Novo Nordisk

PR-M10-19-NI-050Nov 01, 2019
Patient Deaths Lead to FDA Safety Warning on Hepatitis C Medication
Safety Warning

Patient Deaths Lead to FDA Safety Warning on Hepatitis C Medication

Nice Insight

PAO-M09-19-NI-011Sep 11, 2019
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
FDA Breakthrough

Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection

Nice Insight

PR-M08-19-NI-071Aug 26, 2019
AbbVie
Drug Development

AbbVie's MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis

AbbVie

PR-M11-18-NI-053Nov 15, 2018
MYR Pharma
Hepatitis

MYR Pharma Announces Presentation of Interim Results of MYR 203, a Phase 2 Study of Myrcludex in Combination with Pegylated Interferon in Chronic Hepatitis Delta

MYR Pharma

PR-M10-18-NI-107Oct 31, 2018
Researchers at the University of Colorado Develop New Combination Hepatitis C Treatment
Combination Therapy

Researchers at the University of Colorado Develop New Combination Hepatitis C Treatment

Emilie Branch

Pharma's Almanac

PAO-M08-17-NI-035Aug 25, 2017
Vosevi Hepatitis C Treatment Approved by the FDA
FDA

Vosevi Hepatitis C Treatment Approved by the FDA

Nigel Walker

Nice Insight

PAO-M07-17-NI-028Jul 25, 2017
1 / 1